Monopar Therapeutics Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $1.1M | $18.1M | $17.8M |
| Jun 2022 | $2.2M | $16.7M | $16.5M |
| Sep 2022 | $1.9M | $14.4M | $14.3M |
| Dec 2022 | $3.1M | $13.2M | $8.2M |
| Mar 2023 | $2.9M | $11.8M | $5.7M |
| Jun 2023 | $2.5M | $10.3M | $7.2M |
| Sep 2023 | $2.0M | $8.6M | $5.5M |
| Dec 2023 | $1.8M | $7.3M | $7.3M |
| Mar 2024 | $1.4M | $8.9M | $7.8M |
| Jun 2024 | $1.1M | $7.2M | $6.1M |
| Sep 2024 | $1.1M | $6.1M | $6.0M |
| Dec 2024 | $5.3M | $60.3M | $45.8M |
| Mar 2025 | $1.5M | $55.1M | $39.7M |
| Jun 2025 | $1.7M | $53.9M | $39.5M |
| Sep 2025 | $2.6M | $144.2M | $127.7M |
| Dec 2025 | $2.9M | $140.7M | $61.8M |
| Mar 2026 | $2.6M | $138.0M | $52.5M |
| Jun 2026 | $4.1M | $135.0M | $52.8M |